CJC-1295 Dosage Guide

Complete guide to CJC-1295 dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

CJC-1295 DAC: 1-2mg weekly. CJC-1295 no DAC (Mod GRF 1-29): 100-300mcg 2-3 times daily.

Administration Method

Subcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.

Side Effects to Monitor

Water retention, tingling in extremities, potential increase in cortisol and prolactin levels.

Safety Considerations & Risks

May affect blood glucose levels. Long-term effects on pituitary function not fully understood.